November 13, 2023 MedinCell applauds Teva and Royalty Pharma collaboration to further accelerate olanzapine LAI program Read press release
November 6, 2023 MedinCell at the 2023 Jefferies Global Healthcare Conference -London, 14-16 November Read press release
October 4, 2023 MedinCell and the European Investment Bank (EIB) have replaced a financial covenant of their ongoing loan agreement to better fit with MedinCell business model Read press release
September 6, 2023 US Biopharma Financial & IR Strategy Veteran Dr Grace Kim joins MedinCell Read press release
August 30, 2023 MedinCell announces successful completion of patient enrollment in the Phase 3 study of F14 (mdc-CWM), a first-in-class therapy for localized pain relief after Total Knee Replacement Read press release